Cargando…

Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Dori, Amir, Guglieri, Michela, Scutifero, Marianna, Passamano, Luigia, Trabacca, Antonio, Politano, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore Srl 2022
Materias:	Retraction Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299955/ https://www.ncbi.nlm.nih.gov/pubmed/35919205

Ejemplares similares

Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up
por: Dori, Amir, et al.
Publicado: (2021)

Therapeutic approach with Ataluren in Duchenne symptomatic carriers with nonsense mutations in dystrophin gene. Results of a 9-month follow-up in a case report
por: D’AMBROSIO, PAOLA, et al.
Publicado: (2018)

Xp21 contiguous gene deletion syndrome presenting as Duchenne muscular dystrophy and glycerol kinase deficiency associated with intellectual disability: case report and review literature
por: Pizza, Antonella, et al.
Publicado: (2023)

Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy
por: Viggiano, Emanuela, et al.
Publicado: (2023)

Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
por: Namgoong, John Hyun, et al.
Publicado: (2016)

Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients
por: PASSAMANO, LUIGIA, et al.
Publicado: (2012)

Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1
por: Scutifero, Marianna, et al.
Publicado: (2022)

Early treatment with Ataluren of a 2-year-old boy with nonsense mutation Duchenne dystrophy
por: Bitetti, Ilaria, et al.
Publicado: (2021)

The Role of TRPM4 Gene Mutations in Causing Familial Progressive Cardiac Conduction Disease: A Further Contribution
por: Palladino, Alberto, et al.
Publicado: (2022)

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021)

CLCN1 Molecular Characterization in 19 South-Italian Patients With Dominant and Recessive Type of Myotonia Congenita
por: Orsini, Chiara, et al.
Publicado: (2020)

Statement of Retraction
Publicado: (2012)

AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 2012;61:3114–3125
por: Zhang, W, et al.
Publicado: (2013)

Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy. Diabetes. 19 November 2012 [Epub ahead of print]
por: Rincon, N, et al.
Publicado: (2013)

Retraction statement
Publicado: (2014)

Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy. Diabetes 2009;58:934–945. DOI: 10.2337/db08-1287
por: Francis, George, et al.
Publicado: (2014)

Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455
por: Berglund, Eric D., et al.
Publicado: (2016)

Statement of Retraction. Nuts as a Replacement for Carbohydrates in the Diabetic Diet. Diabetes Care 2011;34:1706–1711. DOI: 10.2337/dc11-0338
por: Jenkins, David J.A., et al.
Publicado: (2016)

Complex care needs of patients with late-stage HIV disease: A retrospective study
por: Halman, Mark, et al.
Publicado: (2013)

Statement of Retraction. Gerolama Condorelli, Giovanni Vigliotta, Alessandra Trencia, Maria Alessandra Maitan, Matilde Caruso, Claudia Miele, Francesco Oriente, Stefania Santopietro, Pietro Formisano, and Francesco Beguinot. Protein Kinase C (PKC)-α Activation Inhibits PKC-ζ and Mediates the Action of PED/PEA-15 on Glucose Transport in the L6 Skeletal Muscle Cells. Diabetes 2001;50:1244–1252. DOI: 10.2337/diabetes.50.6.1244. PMID: 11375323
Publicado: (2019)

Statement of Retraction. Matilde Caruso, Claudia Miele, Andrea Oliva, Gerolama Condorelli, Francesco Oriente, Gabriele Riccardi, Brunella Capaldo, Francesca Fiory, Domenico Accili, Pietro Formisano, and Francesco Beguinot. The IR(1152) Mutant Insulin Receptor Selectively Impairs Insulin Action in Skeletal Muscle but Not in Liver. Diabetes 2000;49:1194–1202. DOI: 10.2337/diabetes.49.7.1194. PMID: 10909978
Publicado: (2019)

Statement of Retraction. Francesco Oriente, Salvatore Iovino, Serena Cabaro, Angela Cassese, Elena Longobardi, Claudia Miele, Paola Ungaro, Pietro Formisano, Francesco Blasi, and Francesco Beguinot. Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase. Diabetes 2011;60:138–147. DOI: 10.2337/db10-0860. PMID: 20864515
Publicado: (2019)

Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
por: Prada, Patricia O., et al.
Publicado: (2017)

Statement of Retraction. The SNARE Protein SNAP23 and the SNARE-Interacting Protein Munc18c in Human Skeletal Muscle Are Implicated in Insulin Resistance/Type 2 Diabetes. Diabetes 2010;59:1870–1878. DOI: 10.2337/db09-1503. PMID: 20460426
por: Boström, Pontus, et al.
Publicado: (2017)

Statement of Retraction. Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets. Diabetes 2008;57:645–653. DOI: 10.2337/db07-0847; and erratum. Diabetes 2014:63:3974. DOI: 10.2337/db14-er11
por: Shu, Luan, et al.
Publicado: (2017)

Statement of Retraction. Physical Exercise Reduces Circulating Lipopolysaccharide and TLR4 Activation and Improves Insulin Signaling in Tissues of DIO Rats. Diabetes 2011;60:784–796. DOI: 10.2337/db09-1907
por: Oliveira, Alexandre G., et al.
Publicado: (2016)

Statement of Retraction. Tub Has a Key Role in Insulin and Leptin Signaling and Action In Vivo in Hypothalamic Nuclei. Diabetes 2013;62:137–148. DOI: 10.2337/db11-1388
por: Prada, Patrícia O., et al.
Publicado: (2017)

Statement of Retraction. Lucia Garcia-Guerra, Iria Nieto-Vázquez, Rocio Vila-Bedmar, María Jurado-Pueyo, Guillermo Zalba, Javier Díez, Cristina Murga, Sonia Fernández-Veledo, Federico Mayor, and Margarita Lorenzo. G Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity. Diabetes 2010;59:2407–2417. https://doi.org/10.2337/db10-0771
Publicado: (2020)

Statement of Retraction. Iria Nieto-Vázquez, Sonia Fernández-Veledo, Cristina de Alvaro, and Margarita Lorenzo. Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle. Diabetes 2008;57:3211–3221. https://doi.org/10.2337/db07-1062
Publicado: (2020)

Statement of Retraction
Publicado: (2020)

Statement of Retraction. Christopher Lipina, Katherine Macrae, Tamara Suhm, Cora Weigert, Agnieszka Blachnio-Zabielska, Marcin Baranowski, Jan Gorski, Karl Burgess, and Harinder S. Hundal. Mitochondrial Substrate Availability and Its Role in Lipid-Induced Insulin Resistance and Proinflammatory Signaling in Skeletal Muscle. Diabetes 2013;62:3426–3436. DOI: 10.2337/db13-0264. PMID: 23733201. PMCID: PMC3781443
Publicado: (2021)

Statement of Retraction. Christopher Lipina, Clare Stretton, Simon Hastings, Jonathan S. Hundal, Ken Mackie, Andrew J. Irving, and Harinder S. Hundal. Regulation of MAP Kinase–Directed Mitogenic and Protein Kinase B–Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells. Diabetes 2010;59:375–385. DOI: 10.2337/db09-0979. PMID: 19933999. PMCID: PMC2809953
Publicado: (2021)

Statement of Retraction. Qilong Wang, Zhonglin Xie, Wencheng Zhang, Jun Zhou, Yue Wu, Miao Zhang, Huaiping Zhu, and Ming-Hui Zou. Myeloperoxidase Deletion Prevents High-Fat Diet–Induced Obesity and Insulin Resistance. Diabetes 2014;63:4172–4185. DOI: 10.2337/db14-0026. PMID: 25024373. PMCID: PMC4238009
Publicado: (2021)

Statement of Retraction
Publicado: (2022)

Statement of Retraction: Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer
Publicado: (2022)

Retraction Statement
Publicado: (2022)

Effect of Ataluren on dystrophin mutations
por: Berger, Joachim, et al.
Publicado: (2020)

Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
por: Finkel, Richard S., et al.
Publicado: (2013)

One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?
por: Ruggiero, Lucia, et al.
Publicado: (2018)

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
por: Kourakis, Stephanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fof23nv2ptt4n15rrmnkftr5q2